Pharmacological management of STEMI post percutaneous coronary intervention
Antiplatelet Agents in Acute Coronary Syndromes
Management of patients after primary percutaneous coronary intervention for myocardial infarction | The BMJ
Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) – 2020
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial - The Lancet
Cardiac Catheterization: A Review for Pharmacists
Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery - ScienceDirect
Cardiac-Related Medications Given after the Study Procedure.* | Download Table
Creating a Same-Day Discharge PCI Program Using Transradial | DAIC
Medication Management and Secondary Prevention Post PCI - ppt download
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Repor
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.,JAMA - X-MOL
EVEROLIMUSELUTING STENTS OR BYPASS SURGERY FOR LEFT MAIN
Basics of pci
Ticagrelor With or Without Aspirin After Complex PCI - ScienceDirect
Detailed overview of potential mediators of post-PCI outcomes,... | Download Scientific Diagram
Medication Prescription Rates Before and After Publication of COURAGE... | Download Table
After PCI for MI, 90-day prescriptions confer better medication adherence, fewer changes
Cardiac Catheterization: A Review for Pharmacists
Sex-related impacts on clinical outcomes after percutaneous coronary intervention | Scientific Reports
Cardiac Catheterization: A Review for Pharmacists
